SEC Filing Details
Document Details
Form
Filing Date
Feb 22, 2023
Document Date
Feb 18, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
KASINGER JAMES R.